National Bank Of Canada Rocket Pharmaceuticals, Inc. Transaction History
National Bank Of Canada
- $62.9 Billion
- Q2 2024
A detailed history of National Bank Of Canada transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 35 shares of RCKT stock, worth $763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35Holding current value
$763% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$386 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$200 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$135 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$127 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$94.3 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.65B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...